ArticleWorld journal of clinical oncology2025
Therapeutic insights into epidermal growth factor receptor/reactive oxygen species proto-oncogene 1-receptor co-mutated non-small cell lung cancer: Crizotinib as a promising option.
Yan Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.